The goals of the Community First Responder Program are to educate communities about opioid misuse and provide resources to these communities including the opioid overdose antidote naloxone (Narcan).
Continue reading "Community First Responder Program"Author: Ian T Lester
RhodyRx – Research, Innovation & Impact
Every discovery starts with a question We have some exciting news… the newest issue of RhodyRx is here! We designed this issue around one simple idea: every discovery starts with a question. And if you’re a part of URI College of Pharmacy, you know that’s where everything begins. We want our students to be curious […]
Continue reading "RhodyRx – Research, Innovation & Impact"Class of 2030 Professional Manual
American Society of Pharmacognosy (APS)
Eligibility: All PharmD and BPS Students Mission: The American Society of Pharmacognosy (ASP) is committed to advancing the field of pharmacognosy and the broader natural products sciences. As an international, nonprofit scientific organization, ASP promotes research excellence, fosters scholarly exchange, and supports the discovery and dissemination of knowledge related to natural molecules
Continue reading "American Society of Pharmacognosy (APS)"Biomedical and Pharmaceutical Sciences Club
Eligibility: BPS Students Mission: The BPS Club aims to provide a supportive community where students can actively engage with the program! Through building meaningful connections with faculty, community mentoring, and engaging opportunities, the club will empower its members to thrive within the College of Pharmacy.
Continue reading "Biomedical and Pharmaceutical Sciences Club"International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Eligibility: All College of Pharmacy Students Mission: The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a global organization dedicated to advancing the science and practice of health economics and outcomes research (HEOR) to improve decision-making in healthcare. The University of Rhode Island ISPOR Student Chapter serves as a platform for students interested in HEOR […]
Continue reading "International Society for Pharmacoeconomics and Outcomes Research (ISPOR)"Dr. Erica Estus Receives Two National Awards from ASCP
Clinical Professor Erica Estus, PharmD, BCGP, FASCP has been nationally recognized for her outstanding contributions to pharmacy education and senior care. At the American Society of Consultant Pharmacists (ASCP) 2025 Annual Meeting & Exhibition in San Diego, she received not one but two of the organization’s top honors: the ASCP Outstanding Faculty Award and the […]
Continue reading "Dr. Erica Estus Receives Two National Awards from ASCP"From the Lab to Capitol Hill: Guiding the Nation’s Health Policy
Patrick Dumas ’16 still remembers the first time he stepped into a URI research lab. Surrounded by equipment he had only seen in textbooks, he felt a spark of possibility. That spark would eventually carry him far beyond the bench.
Continue reading "From the Lab to Capitol Hill: Guiding the Nation’s Health Policy"How URI Prepared Dr. Steve Shen, PhD ’17, for a Career in Biomedical and Pharmaceutical Sciences
Dr. Yuanjun “Steve” Shen, PhD ’17, is a proud graduate of the University of Rhode Island College of Pharmacy’s Pharmaceutical Science program and now serves as an Assistant Professor of Pharmaceutical Sciences at Binghamton University. While at URI, Dr. Shen trained under world-class faculty, gained hands-on research experience, and built the foundation for a career […]
Continue reading "How URI Prepared Dr. Steve Shen, PhD ’17, for a Career in Biomedical and Pharmaceutical Sciences"URI to MIT. Cancer Research to CEO: A Q&A with Kevin Bian, PhD ’19
URI roots, MIT breakthroughs, and a CEO leading the charge against cancer—Kevin Bian’s journey shows where curiosity and resilience can take you From the lab bench at URI to the cutting-edge of cancer research at MIT, Kevin Bian’s journey is fueled by curiosity, resilience, and a commitment to making science matter. As a postdoctoral researcher […]
Continue reading "URI to MIT. Cancer Research to CEO: A Q&A with Kevin Bian, PhD ’19"